RAC1 and neoplasm: Lastly, Akunuru et al. provide further evidence of the overexpression of RAC1 in the more aggressive tumor phenotypes and the beneficial, anti-tumorigenic effect of its inhibition in both general and CSC NSCLC populations [55].